ANAC : Analysis & Opinions

  1. Aquinox Starts Dosing for an Atopic Dermatitis Study - Analyst ...

    January 5, 2015
    Aquinox (AQXP) has started dosing in the phase II KINSHIP study on its atopic dermatitis candidate, AQX-1125.
  2. Investing In Biotech: Is It Worth The Risk?

    September 5, 2014
    Investors shunned biotech after a weak start in 2014. Now that a comeback is in the works, should they reconsider?
Trading Center